» Articles » PMID: 19624600

Length of Storage and in Vitro Immunomodulation Induced by Prestorage Leukoreduced Red Blood Cells

Overview
Journal Transfusion
Specialty Hematology
Date 2009 Jul 24
PMID 19624600
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The relationship between length of storage of red blood cell (RBC) units and biochemical changes has been well studied, but little is known about the progression of cellular immunomodulative properties in blood recipients. This study aims to quantify in vitro T-cell activation and cytokine release by white blood cells, after incubation with supernatants from leukoreduced RBCs.

Study Design And Methods: Whole blood cultures were incubated with supernatant from five leukoreduced RBC units stored for 1, 6, 10, 15, 24, and 42 days. Supernatant-induced T-cell activation was evaluated by quantifying CD25 expression. Supernatant-induced cytokine production was determined by measuring interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF)-alpha levels.

Results: No cytokines were detected in RBC supernatants even after 42 days of storage. However, IL-6 levels in whole blood culture increased significantly when incubated with supernatant from RBC units stored for 1, 6, and 15 days, by factors of 1.7 +/- 0.3, 1.7 +/- 0.3, and 1.4 +/- 0.3, respectively. TNF-alpha levels were significantly decreased on Days 24 and 42 of storage by factors of 0.50 +/- 0.42 and 0.33 +/- 0.21, respectively. IL-10 levels were significantly increased on Days 1 and 42 of storage by factors of 2.3 +/- 1.3 and 3.2 +/- 2.8, respectively. After an initial increase in IL-6 and TNF-alpha production, there was a significant linear decrease in their levels measured from units stored for longer times. No significant changes in CD25 expression were observed over time.

Conclusion: Although no cytokines were measured in the supernatants from leukoreduced RBCs, these supernatants exhibited variable immunomodulatory effects related to their length of storage.

Citing Articles

Study protocol of the WashT Trial: transfusion with washed versus unwashed red blood cells to reduce morbidity and mortality in infants born less than 28 weeks' gestation - a multicentre, blinded, parallel group, randomised controlled trial.

Stark M, Collins C, Andersen C, Crawford T, Sullivan T, Bednarz J BMJ Open. 2023; 13(7):e070272.

PMID: 37487676 PMC: 10373745. DOI: 10.1136/bmjopen-2022-070272.


Carbapenem-resistant infections in critically ill children: Prevalence, risk factors, and impact on outcome in a large tertiary pediatric hospital of China.

Huang W, Wei X, Xu G, Zhang X, Wang X Front Public Health. 2023; 11:1088262.

PMID: 36844819 PMC: 9948009. DOI: 10.3389/fpubh.2023.1088262.


Red Blood Cell-Derived Microparticles Exert No Cancer Promoting Effects on Colorectal Cancer Cells In Vitro.

Fischer D, Thies F, Awad O, Brat C, Meybohm P, Baer P Int J Mol Sci. 2022; 23(16).

PMID: 36012587 PMC: 9409112. DOI: 10.3390/ijms23169323.


Effect of washed versus unwashed red blood cells on transfusion-related immune responses in preterm newborns.

Crawford T, Andersen C, Hodyl N, Robertson S, Stark M Clin Transl Immunology. 2022; 11(3):e1377.

PMID: 35284073 PMC: 8907378. DOI: 10.1002/cti2.1377.


Predictors for Perioperative Blood Transfusion in Patients Undergoing Open Cystectomy and Urinary Diversion and Development of a Nomogram: An Observational Cohort Study.

Engel D, Beilstein C, Jerney P, Furrer M, Burkhard F, Loffel L J Clin Med. 2021; 10(13).

PMID: 34202030 PMC: 8267645. DOI: 10.3390/jcm10132797.